Fort Worth, TX, United States of America

Bryan H Huynh

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alcon Research, Ltd.. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Bryan H Huynh

Introduction

Bryan H Huynh is an accomplished inventor based in Fort Worth, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infections. His innovative work has led to the development of a patent that addresses critical medical needs.

Latest Patents

Bryan H Huynh holds a patent for "Finafloxacin suspension compositions." This invention relates to methods for treating ophthalmic, otic, or nasal infections by using a suspension composition that includes finafloxacin or its derivatives. The patent also covers antimicrobial compositions suitable for treating these types of infections.

Career Highlights

Throughout his career, Bryan has worked with notable companies such as Alcon Research, Ltd. and Merlion Pharmaceuticals Pte. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to important advancements in medical treatments.

Collaborations

Bryan has collaborated with esteemed colleagues, including Brent G Boudreaux and Mark J Bridle. These partnerships have fostered a productive environment for innovation and development in the pharmaceutical industry.

Conclusion

Bryan H Huynh's contributions to the field of pharmaceuticals through his patent and collaborations highlight his commitment to improving medical treatments. His work continues to impact the way infections are treated, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…